ArticleThyroid : official journal of the American Thyroid Association2020
Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Article in Thyroid : official journal of the American Thyroid Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effectiveness and potential mechanism of Jiawei-Xiaoyao-San for hyperthyroidism: a systematic review.Frontiers in endocrinology · 2023Pooled it
- Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: a systematic review and meta-analysis.Sao Paulo medical journal = Revista paulista de medicina · 2023Pooled it
- Trial
- Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment.Frontiers in endocrinology · 2022Trial
- The decline of iodine therapy in the treatment of Graves' disease in a hospital center: a 20-year analysis.Archives of endocrinology and metabolism · 2026Article
- Sustained Control of Hyperthyroidism in Graves' Disease: Comparison of Thyroidectomy and Long-Term Antithyroid Treatment.International journal of endocrinology and metabolism · 2026Article
- Graves' disease: review of disease characteristics, burden, and treatments.Frontiers in endocrinology · 2026Review
- Medical Treatment of Hyperthyroidism; Efficacy and Safety Considerations.Archives of Iranian medicine · 2025Review
- 2‑Thiouracil Antithyroid Drug Delivery with Functionalized BCACS omega · 2025Article
- The evolving therapeutic landscape of Graves' disease in adults: present and future.European thyroid journal · 2025Review
- A short review of current knowledge regarding long-term treatment of Graves' disease with antithyroid drugs.Hormones (Athens, Greece) · 2025Review
- Unveiling Risk Factors for Treatment Failure in Patients with Graves' Disease: A Nationwide Cohort Study in Korea.Endocrinology and metabolism (Seoul, Korea) · 2025Article
- A narrative review of long-term inorganic iodine monotherapy for Graves' disease with a historical relationship between iodine and thyroid.Endocrine journal · 2025Review
- Targeted immunotherapies for Graves' thyroidal & orbital diseases.Frontiers in immunology · 2025Review
- A 2023 International Survey of Clinical Practice Patterns in the Management of Graves Disease: A Decade of Change.The Journal of clinical endocrinology and metabolism · 2024Article
- Dynamic Risk Model for the Medical Treatment of Graves' Hyperthyroidism according to Treatment Duration.Endocrinology and metabolism (Seoul, Korea) · 2024Article
- Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.BMC endocrine disorders · 2024Article
- MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.JAMA network open · 2024Article
- Graves disease is associated with increased risk of clinical Alzheimer's disease: evidence from the Medicare system.Clinical diabetes and endocrinology · 2024Article
- Ultrasound combined with Ki-67 to construct the prognostic model for radioactive iodine therapy outcomes in Graves' disease patients.Endocrine connections · 2024Article
Corrections and comments
- Commented on by
- Erratum issuedCorrection to:2020
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
31973681What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.